These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34627000)

  • 1. Molecular docking and simulation of the interaction of sulbactam with Acinetobacter baumannii BaeSR and AdeSR.
    Ho KH; Su SC; Lee KR
    Biochem Biophys Res Commun; 2021 Nov; 580():81-86. PubMed ID: 34627000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and Mechanism of Spontaneous Resistance to Sulbactam Combined with the Novel β-Lactamase Inhibitor ETX2514 in Clinical Isolates of Acinetobacter baumannii.
    McLeod SM; Shapiro AB; Moussa SH; Johnstone M; McLaughlin RE; de Jonge BLM; Miller AA
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Multidrug-Resistant
    Barnes MD; Kumar V; Bethel CR; Moussa SH; O'Donnell J; Rutter JD; Good CE; Hujer KM; Hujer AM; Marshall SH; Kreiswirth BN; Richter SS; Rather PN; Jacobs MR; Papp-Wallace KM; van den Akker F; Bonomo RA
    mBio; 2019 Mar; 10(2):. PubMed ID: 30862744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antibacterial activity of sulbactam-durlobactam in combination with other antimicrobial agents against Acinetobacter baumannii-calcoaceticus complex.
    McLeod SM; Carter NM; Bradford PA; Miller AA
    Diagn Microbiol Infect Dis; 2024 Jul; 109(3):116344. PubMed ID: 38735147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bactericidal effect of sulbactam against Acinetobacter baumannii ATCC 19606 studied by 2D-DIGE and mass spectrometry.
    Lin CH; Su SC; Ho KH; Hsu YW; Lee KR
    Int J Antimicrob Agents; 2014 Jul; 44(1):38-46. PubMed ID: 24837410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OXA-23 Is a Prevalent Mechanism Contributing to Sulbactam Resistance in Diverse Acinetobacter baumannii Clinical Strains.
    Yang Y; Xu Q; Li T; Fu Y; Shi Y; Lan P; Zhao D; Chen Q; Zhou Z; Jiang Y; Peleg AY; Yu Y
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30348663
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains.
    Higgins PG; Wisplinghoff H; Stefanik D; Seifert H
    Antimicrob Agents Chemother; 2004 May; 48(5):1586-92. PubMed ID: 15105109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Antimicrobial Peptide SAAP Mutant as a Better Adjuvant to Sulbactam-Based Treatments Against Clinical Strains of XDR Acinetobacter baumannii.
    Naha A; Ramaiah S
    Probiotics Antimicrob Proteins; 2024 Apr; 16(2):459-473. PubMed ID: 36971982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced bacterial killing with colistin/sulbactam combination against carbapenem-resistant Acinetobacter baumannii.
    Bian X; Liu X; Feng M; Bergen PJ; Li J; Chen Y; Zheng H; Song S; Zhang J
    Int J Antimicrob Agents; 2021 Feb; 57(2):106271. PubMed ID: 33352235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
    Turk Dagi H; Kus H; Arslan U; Tuncer I
    Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of resistance to ciprofloxacin, ampicillin/sulbactam and imipenem in Acinetobacter baumannii clinical isolates in Taiwan.
    Chiu CH; Lee HY; Tseng LY; Chen CL; Chia JH; Su LH; Liu SY
    Int J Antimicrob Agents; 2010 Apr; 35(4):382-6. PubMed ID: 20138741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic/pharmacodynamic evaluation of sulbactam against Acinetobacter baumannii in in vitro and murine thigh and lung infection models.
    Yokoyama Y; Matsumoto K; Ikawa K; Watanabe E; Shigemi A; Umezaki Y; Nakamura K; Ueno K; Morikawa N; Takeda Y
    Int J Antimicrob Agents; 2014 Jun; 43(6):547-52. PubMed ID: 24796218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in imipenem, meropenem, sulbactam, and colistin nonsusceptibility trends among three phenotypically undifferentiated Acinetobacter baumannii complex in a medical center in Taiwan, 1997-2007.
    Liang-Yu C; Kuo SC; Liu CY; Luo BS; Huang LJ; Lee YT; Chen CP; Chen TL; Fung CP
    J Microbiol Immunol Infect; 2011 Oct; 44(5):358-63. PubMed ID: 21524973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
    Zhao C; Xie W; Zhang W; Ye Z; Wu H
    Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of sulbactam antibacterial activity and resistance determinants in Acinetobacter baumannii.
    Penwell WF; Shapiro AB; Giacobbe RA; Gu RF; Gao N; Thresher J; McLaughlin RE; Huband MD; DeJonge BL; Ehmann DE; Miller AA
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1680-9. PubMed ID: 25561334
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    McLeod SM; Moussa SH; Hackel MA; Miller AA
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988095
    [No Abstract]   [Full Text] [Related]  

  • 17. Durlobactam, a Broad-Spectrum Serine β-lactamase Inhibitor, Restores Sulbactam Activity Against Acinetobacter Species.
    Papp-Wallace KM; McLeod SM; Miller AA
    Clin Infect Dis; 2023 May; 76(Suppl 2):S194-S201. PubMed ID: 37125470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
    Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M
    J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of tigecycline in combination with cefoperazone-sulbactam against multidrug-resistant Acinetobacter baumannii.
    Liu B; Bai Y; Liu Y; Di X; Zhang X; Wang R; Wang J
    J Chemother; 2015 Oct; 27(5):271-6. PubMed ID: 25068186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the efficacy of colistin/sulbactam combination on carbapenem-resistant Acinetobacter baumannii strains].
    Çetinkol Y; Telli M; Altunçekiç Yıldırım A; Çalgın MK
    Mikrobiyol Bul; 2016 Jul; 50(3):460-5. PubMed ID: 27525401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.